Global Vaccine Market to Grow at 10.33% During 2022-2027, Impelled by Rapid Outbreak of COVID-19

March 09, 2021

According to the latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global vaccine market is expected to exhibit a CAGR of 10.33% during 2022-2027. A vaccine refers to a biological component that is prepared by utilizing chemical drugs and disease-causing microorganisms in their weakened form. Upon being injected into the human body, it acts as antigens in disease prevention and stimulates the production of antibodies against several pathogens. Vaccines are thoroughly tested before getting clinical approval to ensure that they are safe and effective in nature. They are widely used for preventing numerous life-threatening diseases, such as polio, measles, influenza, tetanus, diphtheria, meningitis and hepatitis. Consequently, they are increasingly used for immunization procedures across clinics, hospitals, and vaccination centers as well as for research and development (R&D) purposes in clinical laboratories and research institutes.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Vaccine Market Trends:

The global market is primarily driven by the increasing prevalence of infectious diseases across the globe. This is supported by the rising awareness regarding the benefits of effective immunization for eradicating these infections, which has significantly propelled the demand for vaccines. The market is further driven by the numerous initiatives undertaken by several non-profit organizations to promote the importance of immunization among the masses, especially in the endemic and rural regions. Governments of numerous countries are also introducing various free-of-cost vaccination programs in an attempt to encourage individuals to get vaccinated, thereby creating a positive outlook for the market. Moreover, various pharmaceutical companies are now heavily investing in the R&D of improved and updated vaccines for various fatal medical ailments. Additionally, the rapid outbreak of the COVID-19 pandemic across the globe has impelled researchers to focus on the development of an effective novel vaccine against the coronavirus. Coupled with the increasing government support and funding for vaccine development, this is expected to create a positive outlook for the market. 

Market Summary:

  • Based on the technology, the market has been segmented into conjugate, inactivated and subunit, live attenuated, recombinant, toxoid, and others.
  • On the basis of the patient type, the market has been bifurcated into paediatric and adult.
  • The market has been analyzed on the basis of the indication into bacterial diseases [meningococcal, pneumococcal, diphtheria/tetanus/pertussis (DPT), tuberculosis, haemophilus influenzae (Hib), typhoid and others] and viral diseases [hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Japanese encephalitis, rubella, polio, rabies, dengue and others].
  • Based on the route of administration, the market has been segregated into intramuscular and subcutaneous administration, oral administration and others.
  • Based on the product type, the market has been categorized into multivalent and monovalent vaccines.
  • The market has been analyzed on the basis of the treatment type into preventive and therapeutic vaccines.
  • Based on the end user, the market has been classified into hospitals, clinics, vaccination centres, academic and research institutes, and others.
  • On the basis of the distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, institutional sales and others.
  • Region-wise, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and Middle East and Africa (Turkey, GCC Countries, Israel and others). 
  • The competitive landscape of the market has been examined, with some of the key players being Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bharat Biotech International Limited, Bavarian Nordic A/S, CSL Limited, Daiichi Sankyo Company, Limited, Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson & Johnson, Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi Pasteur SA (Sanofi SA), Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited.

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Vaccine Market to Grow at 10.33% During 2022-2027, Impelled by Rapid Outbreak of COVID-19
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More